Cargando…

Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty

BACKGROUND: The safety and efficacy of an oral anticoagulant (OAC) treatment and the difference between direct OACs (DOACs) and warfarin in nonsevere frail elderly patients with AF are unclear. METHODS: This was a retrospective and observational study of 354 patients over 80 years of age with nonsev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shinohara, Masaya, Wada, Ryou, Yao, Shintaro, Yano, Kensuke, Akitsu, Katsuya, Koike, Hideki, Kinoshita, Toshio, Yuzawa, Hitomi, Suzuki, Takeya, Fujino, Tadashi, Ikeda, Takanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898529/ https://www.ncbi.nlm.nih.gov/pubmed/31844468 http://dx.doi.org/10.1002/joa3.12231

Ejemplares similares

Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty
por: Noro, Mahito
Publicado: (2019)

The Difference in the Changes of Indoxyl Sulfate after Catheter Ablation among Atrial Fibrillation Patients with and without Kidney Dysfunction
por: Koike, Hideki, et al.
Publicado: (2020)

Assessment of drug-induced proarrhythmias due to pilsicainide in patients with atrial tachyarrhythmias
por: Koike, Hideki, et al.
Publicado: (2016)

Relationship between the degree of renal dysfunction and the safety and efficacy outcomes in patients with atrial fibrillation receiving direct oral anticoagulants
por: Wada, Ryo, et al.
Publicado: (2021)

Transient, Marked ST-Segment Elevation During Successful Epicardial Substrate Ablation in a Patient With Brugada Syndrome
por: Fujino, Tadashi, et al.
Publicado: (2019)

The bleeding phenotype in people with nonsevere hemophilia
por: Kloosterman, Fabienne R., et al.
Publicado: (2022)

Joint status of patients with nonsevere hemophilia A
por: Zwagemaker, Anne‐Fleur, et al.
Publicado: (2022)

Increased blood pressure after nonsevere COVID-19
por: Schmidt-Lauber, Christian, et al.
Publicado: (2023)

ATYPICAL PRESENTATION OF MUCORMYCOSIS IN A NONSEVERE COVID-19 PATIENT
por: TRAN, STEVEN, et al.
Publicado: (2022)

Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy
por: Romano, Lorenzo G.R., et al.
Publicado: (2023)

Decision Tree Model for Hematology/Oncology Patients with Severe and Nonsevere Sepsis
por: Munger, Jessica A., et al.
Publicado: (2018)

Prognostic nomogram on admission predicting progression for patients with nonsevere COVID-19
por: Wang, Zhi, et al.
Publicado: (2021)

Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19
por: Veyre, Florian, et al.
Publicado: (2020)

GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

Friedman Score in Relation to Compliance and Treatment Response in Nonsevere Obstructive Sleep Apnea
por: Berg, Lars M., et al.
Publicado: (2020)

Development and external validation of a prognostic tool for nonsevere COVID-19 inpatients
por: Luo, Ensi, et al.
Publicado: (2023)

Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series
por: Murakami, Yoshiki, et al.
Publicado: (2021)

Feasibility and utility of frailty assessment in the over 80 s on critical care
por: Charles, B, et al.
Publicado: (2011)

Development and Validation of a Nomogram for Predicting the Disease Progression of Nonsevere Coronavirus Disease 2019
por: Li, Xue-lian, et al.
Publicado: (2021)

Transcatheter Aortic Valve Replacement in Patients With Reduced Ejection Fraction and Nonsevere Aortic Stenosis
por: Ludwig, Sebastian, et al.
Publicado: (2023)

Predictors of early progression to severe sepsis or shock among emergency department patients with nonsevere sepsis
por: Holder, Andre L., et al.
Publicado: (2016)

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
por: Amarenco, Pierre, et al.
Publicado: (2020)

Nonsevere Acute Respiratory Syndrome Human Coronaviruses in Children Hospitalized with Acute Lower Respiratory Infection
por: Das, Rashmi Ranjan, et al.
Publicado: (2021)

Oral Antihypertensives for Nonsevere Pregnancy Hypertension: Systematic Review, Network Meta- and Trial Sequential Analyses
por: Bone, Jeffrey N., et al.
Publicado: (2022)

Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
por: Pitre, Tyler, et al.
Publicado: (2022)

In Vitro Assays for Diagnosis of Drug-Induced Nonsevere Exanthemas: A Systematic Review and Meta-Analysis
por: Drygala, Szymon, et al.
Publicado: (2022)

Efficacy of Oxymetholone in Severe and Nonsevere Acquired Aplastic Anemia: A Propensity Score Matching Analysis
por: Pengthina, Worachaya, et al.
Publicado: (2022)

Early antiviral and supervisory dexamethasone treatment improve clinical outcomes of nonsevere COVID-19 patients
por: Sitasuwan, Tullaya, et al.
Publicado: (2022)

Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case‒control study
por: van Velzen, Alice S., et al.
Publicado: (2020)

Brief Report: Retrospective Evaluation on the Efficacy of Lopinavir/Ritonavir and Chloroquine to Treat Nonsevere COVID-19 Patients
por: Gao, Guiju, et al.
Publicado: (2020)

A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation
por: Chen, Yuanfang, et al.
Publicado: (2021)

Pathogenic DNM1 Gene Variant Presenting With Unusually Nonsevere Neurodevelopmental Phenotype: A Case Report
por: Choi, Elaine, et al.
Publicado: (2021)

The effect of casirivimab with imdevimab on disease progression in nonsevere COVID‐19 patients in a single hospital in Japan
por: Komagamine, Junpei, et al.
Publicado: (2021)

CT-Determined Maximum Pulmonary Artery to Ascending Aorta Diameter Ratio in Nonsevere COVID-19 Patients
por: Abosamak, Mohammed Fawzi, et al.
Publicado: (2021)

A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19
por: Cisowska-Adamiak, Małgorzata, et al.
Publicado: (2022)

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A
por: Ay, Cihan, et al.
Publicado: (2023)

Impact of frailty on the management of patients with gynecological cancer aged 80 years and older
por: Reiser, Elisabeth, et al.
Publicado: (2020)

Impact of Amino Acid Substitutions in Two Functional Domains of Ku80: DNA-Damage-Sensing Ability of Ku80 and Survival after Irradiation
por: KOIKE, Manabu, et al.
Publicado: (2013)

Inhibitor Risk Stratification and Individualized Treatment in Patients With Nonsevere Hemophilia A: A Single-Institution Practice Audit
por: Sun, Haowei (Linda), et al.
Publicado: (2017)

Lymphocyte percentage and hemoglobin as a joint parameter for the prediction of severe and nonsevere COVID-19: a preliminary study
por: Zhang, Wenping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ldmfmb749pr0192ugoqjngv41a